Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.26
-$1.84-59.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/2/2025
-
GuruFocus
12/2/2025
-
Globe Newswire
12/2/2025
-
GuruFocus
12/2/2025
-
Globe Newswire
11/18/2025
-
GuruFocus
11/18/2025
-
Globe Newswire
10/15/2025
-
Globe Newswire
9/19/2025
-
Globe Newswire
9/12/2025
-
PR Newswire
8/25/2025
-
Slashdot
8/11/2025
-
Globe Newswire
8/4/2025
-
Globe Newswire
8/3/2025
-
Ticker Report
7/19/2025
-
Globe Newswire
7/18/2025
-
PR Newswire
7/18/2025
-
TipRanks Financial Blog
7/14/2025
-
Globe Newswire
7/14/2025
-
Globe Newswire
7/14/2025
-
The Fly
7/14/2025
-
The Fly
7/14/2025
-
PR Newswire
7/14/2025
-
Finbold Stock News
7/14/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 13, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
609 375 2227
Address
100 Overlook Center
Princeton, NJ 08540
Princeton, NJ 08540
Country
Year Founded
--
Business Description
Sector
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding...
more